ResMed Inc.
ResMed Inc. (RMD) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · RMD · as of Sep 30, 2024
Ownership Breakdown
850
Institutional Holders
▲ 38 vs Q2
$21.28B
Total Inst. Value
▲ $4.84B vs Q2
145.06M
Shares Outstanding
freeFloat 99.38%
87.26M
13F Shares Held
▲ 1.35M vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
RMD largest shareholders · institutional ownership
Q3 2024 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
VANGUARD GROUP INC surgical & medical instruments & apparatus | 18.01M | 12.27% | 12.27% | $4.40T | Nov 13, 2024 | ▲ 112.6K |
BLACKROCK, INC. surgical & medical instruments & apparatus | 11.91M | 8.11% | 8.11% | $2.91T | Nov 13, 2024 | NEW |
STATE STREET CORP surgical & medical instruments & apparatus | 6.26M | 4.26% | 4.26% | $1.53T | Nov 14, 2024 | ▲ 116.9K |
BANK OF NEW YORK MELLON CORP surgical & medical instruments & apparatus | 5.71M | 3.89% | 3.89% | $1.39T | Nov 12, 2024 | ▼ 64.3K |
MORGAN STANLEY surgical & medical instruments & apparatus | 4.48M | 3.05% | 3.05% | $1.09T | May 14, 2025 | ▲ 1.08M |
GEODE CAPITAL MANAGEMENT, LLC surgical & medical instruments & apparatus | 3.86M | 2.63% | 2.63% | $939.11B | Nov 12, 2024 | ▲ 380.4K |
INVESCO LTD. surgical & medical instruments & apparatus | 1.76M | 1.20% | 1.20% | $429.40B | Nov 12, 2024 | ▼ 13.8K |
NORTHERN TRUST CORP surgical & medical instruments & apparatus | 1.41M | 96.14% | 96.14% | $344.68B | Nov 13, 2024 | ▼ 53.3K |
SELECT EQUITY GROUP, L.P. surgical & medical instruments & apparatus | 1.06M | 71.92% | 71.92% | $257.84B | Nov 14, 2024 | NEW |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC surgical & medical instruments & apparatus | 924.0K | 62.92% | 62.92% | $225.58B | Nov 12, 2024 | ▲ 14.0K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2024 vs prior quarter
Q3 2024
25
Increased
+3.04M shares3
New Positions
first time holders22
Decreased
−2.36M shares0
Sold Out
fully exitedNet shares change (top 50)
+681.9K
+3.04M / −2.36M
Net new holders
+6
3 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
RMD insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
1
Buy transactions
4
Sell transactions
0.25
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Farrell Michael J. Chairman and CEO | May 7, 2026 | Sale | 4,991 | $207.82 | $1.04M | 466.2K | Form 4 ↗ |
Farrell Michael J. Chairman and CEO | Apr 7, 2026 | Sale | 4,991 | $225.50 | $1.13M | 466.2K | Form 4 ↗ |
Sandercock Brett Chief Financial Officer | Apr 1, 2026 | Sale | 1,000 | $224.31 | $224.3K | 83.5K | Form 4 ↗ |
FARRELL PETER C director | Apr 1, 2026 | Sale | 2,000 | $225.00 | $450.0K | 60.8K | Form 4 ↗ |
Farrell Michael J. Chairman and CEO | Mar 9, 2026 | Sale | 4,991 | $251.03 | $1.25M | 466.2K | Form 4 ↗ |
FARRELL PETER C director | Mar 4, 2026 | Sale | 2,000 | $260.22 | $520.4K | 62.8K | Form 4 ↗ |
Sandercock Brett Chief Financial Officer | Mar 2, 2026 | Sale | 1,000 | $254.30 | $254.3K | 84.5K | Form 4 ↗ |
Farrell Michael J. Chairman and CEO | Feb 9, 2026 | Sale | 4,991 | $273.78 | $1.37M | 466.2K | Form 4 ↗ |
FARRELL PETER C director | Feb 4, 2026 | Sale | 2,000 | $251.31 | $502.6K | 64.8K | Form 4 ↗ |
Rider Michael J Global General Counsel | Feb 4, 2026 | Sale | 50 | $260.00 | $13.0K | 9.7K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
ResMed Inc. (RMD) is primarily owned by institutional investors, who hold approximately 60.2% of total shares outstanding. Company insiders own approximately 0.62%, while retail and public investors account for the remaining 39.22%.
The largest institutional shareholder of ResMed Inc. is VANGUARD GROUP INC, holding approximately 18.01 million shares — equal to 12.27% of outstanding shares — as of September 30, 2024.
A total of 850 institutional investors currently hold RMD stock, with a combined institutional value of approximately $21.28 billion as of the most recent 13F filing period.
Frequently asked questions
RMD ownershipResMed Inc. (RMD) is primarily owned by institutional investors, who hold approximately 60.2% of shares. The largest shareholder is VANGUARD GROUP INC with a 12.27% stake. Company insiders hold 0.62%. Data sourced from SEC Form 13F as of September 30, 2024.